The United States has the most number of coronavirus cases in the world. But rather than viewing the more than 1.5 million confirmed cases negatively, President Donald Trump says that it is just a reflection of his administration's successful testing.
“I view it as a badge of honor, really, it’s a badge of honor,” Donald Trump told reporters on Tuesday, according to Bloomberg. “It’s a great tribute to the testing and all of the work that a lot of professionals have done.”
Based on data from the Worldometers site, there are more than 1.5 million confirmed COVID-19 infections in the U.S. The country also has the highest number of fatalities with over 93 thousand deaths due to the pathogen.
The U.S. also posted the highest number of COVID-19 tests done with almost 13 million Americans already tested for the virus. The country with the second-highest number of tests is Russia with over 7.5 million tests done on its citizens.
Trump explained that it is only natural for the U.S. to have the highest number of confirmed coronavirus infections since it did the most number of tests. “If you’re testing 14 million people, you’re going to find many more cases,” the POTUS said.
He also added that viewed in this light, it’s not necessarily a bad thing to have the most number of cases. “Many of these people aren’t very sick but they still go down as a case, so, actually, the number of cases -- and we’re also a much bigger country than most,” Trump added. “So when we have a lot of cases, I don’t look at that as a bad thing, I look at that as, in a certain respect, as being a good thing because it means our testing is much better.”
But according to Bloomberg, the level of coronavirus testing done in the U.S. is not extraordinary. The nation is still behind Italy, Germany, and the U.K. in terms of the number of tests per 1,000 people. The publication also noted that the country is still facing testing shortages due to delays in the development and manufacturing of testing kits.


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Trump Escalates Greenland Rhetoric, Citing Russia Threat and Pressure on Denmark
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Pedro Sánchez Warns U.S. Greenland Move Could Undermine NATO and Benefit Russia
Reform UK Gains Momentum as Conservative MP Andrew Rosindell Defects Ahead of 2029 Election
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
U.S. Military Kills Al Qaeda-Linked Leader Connected to Deadly ISIS Attack in Syria
Pentagon Prepares Alaska Troops for Possible Minnesota Deployment Amid Immigration Protests
Vietnam Communist Party Congress to Shape Leadership and Economic Strategy
Russian Drone and Missile Attack Disrupts Power and Water in Kyiv
Trump Administration Appeals Judge’s Order Limiting ICE Tactics in Minneapolis
Syrian Government Consolidates Control as Kurdish Forces Withdraw from Key Regions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



